Viewing Study NCT00813956


Ignite Creation Date: 2025-12-24 @ 11:24 PM
Ignite Modification Date: 2026-01-01 @ 7:42 AM
Study NCT ID: NCT00813956
Status: COMPLETED
Last Update Posted: 2016-03-17
First Post: 2008-12-19
Is NOT Gene Therapy: True
Has Adverse Events: False

Brief Title: A Phase 2 Study of Standard Chemotherapy Plus BSI-201 (a PARP Inhibitor) in the Neoadjuvant Treatment of Triple Negative Breast Cancer
Sponsor: Sanofi
Organization:

Study Modules

Identification Module Status Module Sponsor Collaborators Module Oversight Module Description Module Conditions Module Design Module Arms Interventions Module Outcomes Module Eligibility Module Contacts Locations Module References Module